Discovery could lead to much-needed kidney failure treatment

The unwanted activation of an important cell-signaling pathway may play a role in two kidney problems that are major causes of end-stage renal disease, scientists at the Albert Einstein College of Medicine of Yeshiva University have found. Their research, which opens up a novel approach for treating kidney failure, is described in the March issue of Nature Medicine. The study was led by Dr. Katalin Susztak, an assistant professor of medicine (nephrology) at Einstein.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news124557830.html">Discovery could lead to much-needed kidney failure treatment</a></p> <p>The unwanted activation of an important cell-signaling pathway may play a role in two kidney problems that are major causes of end-stage renal disease, scientists at the Albert Einstein College of Medicine of Yeshiva University have found. Their research, which opens up a novel approach for treating kidney failure, is described in the March issue of <i>Nature Medicine</i>. The study was led by Dr. Katalin Susztak, an assistant professor of medicine (nephrology) at Einstein.</p>